AFFF cancer lawsuit

Non-Toxic Alternatives To AFFF Military Firefighting Foam

These updated formulations seek to equal AFFF's fire-extinguishing properties while guaranteeing that long-term environmental and health impacts are minimized

Saturday, April 20, 2024 - Aqueous film-forming foam (AFFF), which contains perfluoroalkyl and poly-fluoroalkyl chemicals (PFAS), which are detrimental to the environment, is being phased out by military firefighting stations worldwide in favor of safer, non-toxic alternatives. Concerning PFAS, which has been connected to serious health problems including cancer, this program aims to address the threats to the environment and human health. AFFF lawsuits seek to hold the manufacturers of products including firefighting foam responsible for their reprehensible conduct. For instance, the search for and use of firefighting foams devoid of per- and polyfluoroalkyl substances (PFAS) has been led by the U.S. Department of Defense (DoD). There has been a thorough and exhaustive search for suitable substitutes because military firefighting relies heavily on conventional AFFF foam, especially when fighting fuel fires. Strategic environmental research programs of the Department of Defense have examined a number of fluorine-free formulae that show promise in terms of efficacy and safety. These updated formulations seek to equal AFFF's fire-extinguishing properties while guaranteeing that long-term environmental and health impacts are minimized. Among NATO nations in Europe, the switch to non-toxic firefighting foams is gathering steam. Several countries, like Norway, have made great progress toward eliminating fluorine from foams used in military installations. Following thorough assessments, the Norwegian Defence Materiel Agency verified that these substitutes were effective in fulfilling military operational requirements while significantly mitigating environmental harm. These actions are a part of larger initiatives by European military groups to adhere to strict EU environmental protection laws. These rules aim to minimize the use of dangerous materials, such as PFAS. These nations set an example for the rest of the world in the movement toward sustainable military practices by incorporating fluorine-free foams, improving their environmental compliance in the process.

The ADF, or Australian Defence Force, is another well-known military force that has embraced non-toxic firefighting foams. In response to increased public criticism and environmental concerns, the ADF began a thorough evaluation of its firefighting foams in 2016. As of 2018, a new fluorine-free recipe was being adopted, in line with Australia's more general environmental objectives. Significant site remediation work was also required in cases where historical AFFF had contaminated water and land sources. The proactive stance taken by the ADF draws attention to the interconnected problems that contemporary militaries must solve with regard to community health, environmental responsibility, and operational capabilities. The Navy in the US developed and tested its PFAS-free firefighting foam as a preventive measure. The goal of this project, spearheaded by the Naval Research Laboratory, is to develop foam that satisfies the exacting performance and safety requirements needed for naval operations. In order to ensure that the new product can function well aboard aircraft carriers and other naval vessels without having the same negative environmental effects as existing foams, the development process takes into account elements like foam spread, cooling capabilities, and re-ignition prevention.

Information provided by AFFFLawsuitCenter.com, a website devoted to providing news about AFFF and PFAS cancer, lymphoma and leukaemia claims, including a free no-cost, no-obligation AFFF Lawsuit Claim.

More Recent AFFF Lawsuit News:

View all AFFF Lawsuit News

No-Cost, No-Obligation Claim Review for Persons or Families of Persons Who Developed Cancer, Lymphoma or Leukaemia After Exposure to Firefighting Foam

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.